Year: 2025
Type: article
Abstract: Fibrosis is a maladaptive response of tissues or organs to adverse stresses, such as chronic inflammation, infection and mechanical injury.It further promotes parenchymal cell loss, abnormal myofibroblast proliferation and excessive extracellular matrix buildup, eventually triggering scar tissue hyperplasia or organ injury.Although a moderate fibrotic response is beneficial for compensatory tissue repair induced by exogenous or endogenous injury, excessive fibrosis is the basis for the promotion of multiorgan pathologies, such as cardiac hypertrophy, idiopathic pulmonary fibrosis, or renal tubulointerstitial fibrosis.In industrialized countries alone, fibrotic diseases account for ~45% of all-cause mortality.Consequently, the development of medications that regulate the activation of growth factors, proliferation of fibrotic effector cells and deposition and degradation of the extracellular matrix is essential.Botanical compounds derived from Chinese medicine are generally considered natural tonics.Among these compounds, astragaloside IV (AS-IV) is a bioactive product isolated from the roots of Astragalus membranaceus Bunge.On the basis of the multitarget therapeutic mechanism of Chinese herbal medicine, AS-IV may have considerable benefits in improving multiorgan fibrosis and complex fibrotic diseases with multisignal cascades.It can effectively alleviate the fibrosis-induced dysfunction of major tissues or organs, including the heart, lungs, kidneys and liver, by regulating the signal transduction of reactive oxygen species/caspase-1/gasdermin D, transforming growth factor-β/Smads, Wnt/β-catenin and sirtuin 1-nuclear factor-κ B. The present review mainly focused on phytomedicine and highlights the potential of AS-IV as an antifibrotic medication.It aimed to provide a novel reference for the application of AS-IV in the nutritional intervention of fibrotic diseases.
Institution: Shanghai University of Sport
Language: English
Subfield: Complementary and alternative medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W7117118239